Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

HEL/BRETEC stock hub

HEL/BRETEC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HEL/BRETECis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.1M

Nasdaq Helsinki

Market data

Price

Recent price action with selectable time range.

HEL/BRETECHEL/BRETEC

—

Loading chart…

In the news

Latest news · HEL/BRETEC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HEL/BRETEC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

Groups with data

Currency

EUR

Showing 84 of 84 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	FI
Exchange	Nasdaq Helsinki
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Last refreshed	2026-05-10
Market cap	EUR 16.1M
Price	EUR 0.01
Price currency	EUR
Sector	Healthcare
Sic	3842
Symbol	hel/BRETEC
Website	https://bioretec.com

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-93.7%
Cagr3y	-61.06%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	7.23

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-93.69%
200-day SMA	0.79
3Y total return	-94.1%
50-day SMA	0.11
50-day SMA vs 200-day SMA	50under200
All Time High	3.75
All Time High Change	-99.68%
All Time High Date	2023-03-30
All Time Low	0.01
All Time Low Change	11.11%
All Time Low Date	2026-04-29
ATR	0.01
Beta	0.54
Beta1y	-1.53
Beta2y	-0.11
Ch YTD	-98
High	0.01
High52	2.32
High52 Date	2025-05-15
High52ch	-99.48%
Low	0.01
Low52	0.01
Low52 Date	2026-04-29
Low52ch	11.11%
Ma50ch	-89.22%
Price vs 200-day SMA	-98.49%
RSI	22.16
RSI Monthly	20.94
RSI Weekly	16.22
Sharpe ratio	0.23x
Sortino ratio	1.11
Tr YTD	-78.24
Tr1m	-65.71%
Tr1w	-3.23%
Tr3m	-71.37%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	810,172,479%
Shares Insiders	0%
Shares Institutions	8.55%
Shares Out	1,341,785,963

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,278,620.35x
Ch1m	-65.71
Ch1w	-3.23
Ch1y	-99.44
Ch3m	-97.37
Ch3y	-99.48
Ch6m	-98.65
Change	-1.64%
Change From Open	-1.64
Close	0.01
Days Gap	0
Dollar Volume	34,174.7
Earnings Date	2026-05-15
F Score	0
Founded	1,998
Is Primary Listing	1
Last Earnings Date	2026-02-13
Ma150	0.56
Ma150ch	-97.86%
Ma20	0.02
Ma20ch	-38.78%
Next Earnings Date	2026-05-15
Open	0.01
Position In Range	50
Price Date	2026-05-08
Relative Volume	1.25x
Tr6m	-85.33%
Volume	2,847,891

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HEL/BRETEC pay a dividend?

Capital-return profile for this ticker.

Performance

HEL/BRETEC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HEL/BRETEC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.6%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HEL/BRETEC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

22.2

Below 30: short-term oversold

Price vs 200-day MA

-98.5%

50/200-day relationship not available

Beta (5Y)

0.54

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HEL/BRETEC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hel/BRETEC stock rating?

hel/BRETEC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hel/BRETEC analysis?

The full report lives at /stocks/hel/BRETEC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hel/BRETEC?

The latest report frames hel/BRETEC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hel/BRETEC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.